US Dollar: Energy shock may delay renewed downtrend – MUFG
MUFG’s Derek Halpenny notes that ongoing Middle East conflict, stronger United States (US) data and crude Oil risks are limiting US Dollar (USD) selling. Better manufacturing and retail figures have not shifted Fed expectations much, but a full hike remains priced by year-end. He warns that any sharp rise in Brent and escalation in conflict could bring forward Fed tightening and delay a renewed downtrend in the Dollar.
Middle East conflict underpins Dollar resilience
"There has been no let-up in the escalation of the conflict in the Middle East which continues to curtail appetite to sell the dollar. Attacks by the US have expanded in the sixth day of renewed fighting. Iran has responded by attacking US bases in Kuwait, Jordan and Bahrain."
"Observable traffic in the Strait of Hormuz is sparse but the advance of crude oil prices have certainly not yet hit a level that would see risk assets come under pressure via higher yields. The broader conditions in risk have worsened with investors continuing to reduce exposure in chip-related stocks as AI valuations continue to be questioned. This is not hurting the US dollar however with the sell-off impacting Asian equities to a greater degree."
"US data releases yesterday have also helped curtail dollar selling. The ‘Philly Fed’ manufacturing index surged (41.4 from 10.3) with most indices within the report pointing to a pick-up in manufacturing activity. Retail sales (control group) remained robust with a 0.5% gain following an upwardly revised 0.8% in May."
"A full hike remains priced by year-end, but spreads have generally remained against the dollar since the US inflation data this week. The risk of a sudden lurch higher in crude oil prices remains the primary deterrent to renewed US dollar selling. While there are reports that some tanker traffic is getting through the Strait of Hormuz it appears to be at a level that could quickly become problematic for energy supply – the IEA says within weeks."
"Another lurch higher in energy prices would see a Fed rate hike brought forward once again and this remains the primary risk to our view of a renewed trend lower for the dollar."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs
AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.
